Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Significant Improvements in Survival for Patients with t(6;9)(p23;q34)/ DEK-NUP214 in Contemporary Trials with Intensification of Therapy: A Report from the Children's Oncology Group

Katherine Tarlock, Todd A. Alonzo, Robert B. Gerbing, Yi-Cheng Wang, Rhonda E. Ries, Betsy A Hirsch, Beverly Lange, William G. Woods, Todd M. Cooper, Alan S. Gamis, Jessica A. Pollard, Richard Aplenc, Anders E. Kolb, Soheil Meshinchi

Blood (2021) 138 (Supplement 1): 519.

https://doi.org/10.1182/blood-2021-147576

Published: 2021

Journal Articles

Acute Myeloid Leukemia with t(6;9)(p23;q34) Is Associated Poor Outcome in Childhood AML Regardless of FLT3/ITD Status, A Report From Children's Oncology Group.

Pilar Palomo Moraleda, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Yaddanapudi Ravindranath, MD, Beverly Lange, MD, William G. Woods, MD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 2541.

https://doi.org/10.1182/blood.V120.21.2541.2541

Published: 2012

Journal Articles

The Ratio of Alternate BIRC5 (Survivin) Splice Variants Correlates with Refractory Disease and Poor Outcome in Children with Acute Myeloid Leukemia: A Report From the Children's Oncology Group,

Andrew S. Moore, MBBS, FRACP, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Beverly Lange, MD, Nyla A. Heerema, PhD, Janet Franklin, MD, MPH, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, Ph.D.

Blood (2011) 118 (21): 3555.

https://doi.org/10.1182/blood.V118.21.3555.3555

Published: 2011

Journal Articles

FACS Analysis of Stat3/5 Signaling Reveals Ligand Sensitivity As a Significant Prognostic Factor in Pediatric AML: A Children's Oncology Group Report

Michele S. Redell, MD, PhD, Marcos J. Ruiz, BS, Robert B. Gerbing, M.A., Todd A. Alonzo, PhD, Beverly Lange, MD, David J. Tweardy, MD, Soheil Meshinchi, MD, PhD

Blood (2011) 118 (21): 938.

https://doi.org/10.1182/blood.V118.21.938.938

Published: 2011

Journal Articles

TET2 Mutations Are Associated with Poor Outcome in Pediatric AML: A Report From the Children's Oncology Group

Matthew A. Kutny, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Daniel Geraghty, PhD, Alan S. Gamis, MD, MPH, Beverly Lange, MD, Nyla A. Heerema, PhD, Janet Franklin, MD, MPH, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Soheil Meshinchi, MD, PhD

Blood (2011) 118 (21): 569.

https://doi.org/10.1182/blood.V118.21.569.569

Published: 2011

Journal Articles

The Prevalence of Fanconi Anemia Among Patients with De Novo Acute Myelogenous Leukemia

Andrzej Rochowski, MD, MSc, FAAP, Philip S Rosenberg, PhD, Todd A. Alonzo, PhD, Robert B. Gerbing, Beverly Lange, MD, Blanche P Alter

Blood (2010) 116 (21): 2232.

https://doi.org/10.1182/blood.V116.21.2232.2232

Published: 2010

Journal Articles

TET2 SNP rs2454206 (I1762V) Correlates with Improved Survival In Pediatric Acute Myelogenous Leukemia, a Report From the Children's Oncology Group

Matthew A. Kutny, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Phoenix A. Ho, MD, Daniel Geraghty, PhD, Beverly Lange, MD, Nyla A. Heerema, Ph.D., Soheil Meshinchi, MD, PhD

Blood (2010) 116 (21): 949.

https://doi.org/10.1182/blood.V116.21.949.949

Published: 2010

Journal Articles

The WT1 synonymous SNP rs16754 Is Associated with Higher mRNA Expression and Predicts Significantly Improved Outcome In Favorable-Risk Pediatric AML: a Report From the Children's Oncology Group

Phoenix A. Ho, MD, Julia Kuhn, BA, Robert B. Gerbing, MA, Jessica A. Pollard, MD, Rong Zeng, BS, Kristen L. Miller, BS, Nyla A. Heerema, Ph.D., Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Janet Franklin, MD, MPH, Beverly Lange, MD, Alan S. Gamis, MD, MPH, Todd A. Alonzo, PhD, Soheil Meshinchi, MD, PhD

Blood (2010) 116 (21): 950.

https://doi.org/10.1182/blood.V116.21.950.950

Published: 2010

Journal Articles

Germline Genetic Variation and Treatment Response on CCG-1891

Dana Sepe, MD, Thomas McWilliams, Jinbo Chen, PhD, Aaron Kershenbaum, PhD, Huaqing Zhao, Mei La, Meenakshi Davidas, PhD, Beverly Lange, MD, Timothy R. Rebbeck, PhD, Richard Aplenc, MD

Blood (2010) 116 (21): 2711.

https://doi.org/10.1182/blood.V116.21.2711.2711

Published: 2010

Journal Articles

Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Phoenix A. Ho, Rong Zeng, Todd A. Alonzo, Robert B. Gerbing, Kristen L. Miller, Jessica A. Pollard, Derek L. Stirewalt, Nyla A. Heerema, Susana C. Raimondi, Betsy Hirsch, Janet L. Franklin, Beverly Lange, Soheil Meshinchi

Blood (2010) 116 (5): 702–710.

https://doi.org/10.1182/blood-2010-02-268953

Published: 2010

Includes: Supplemental data

Journal Articles

RUNX1 Mutations in Pediatric AML: A Report From the Children's Oncology Group.

Matthew A. Kutny, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Kristen Miller, BS, Phoenix Ho, MD, Nyla A. Heerema, PhD, Beverly Lange, MD, Alan S. Gamis, MD, Soheil Meshinchi, MD, PhD

Blood (2009) 114 (22): 2614.

https://doi.org/10.1182/blood.V114.22.2614.2614

Published: 2009

Journal Articles

Prevalence and Clinical Implications of N-RAS Mutations in Childhood AML – A Report From the Children's Oncology Group.

Jason N. Berman, MD, Robert B. Gerbing, PhD, Lillian Sung, MD, Kristen Miller, BS, Jessica A. Pollard, MD, Phoenix Ho, Derek Stirewalt, Jerald Radich, MD, Craig A. Hurwitz, MD, Nyla A. Heerema, PhD, Betsy Hirsch, MD, Susana C. Raimondi, PhD, Beverly Lange, MD, Alan S. Gamis, MD, Janet L. Franklin, MD, MPH, Todd A. Alonzo, PhD, Soheil Meshinchi, MD, PhD

Blood (2009) 114 (22): 3115.

https://doi.org/10.1182/blood.V114.22.3115.3115

Published: 2009

Journal Articles

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Phoenix A. Ho, Todd A. Alonzo, Robert B. Gerbing, Jessica Pollard, Derek L. Stirewalt, Craig Hurwitz, Nyla A. Heerema, Betsy Hirsch, Susana C. Raimondi, Beverly Lange, Janet L. Franklin, Jerald P. Radich, Soheil Meshinchi

Blood (2009) 113 (26): 6558–6566.

https://doi.org/10.1182/blood-2008-10-184747

Published: 2009

Includes: Supplemental data

Journal Articles

Clinical and Serologic Interleukin 2 Receptor α Response to Interleukin-2 in CCG-2961, a Ranomized Phase 3 Trial for Pediatric Acute Myeloid Leukemia.

Beverly Lange, MD, Richard K Yang, Jacek Gan, PhD, Jaqueline A Hank, PhD, Eric Sievers, MD, Robert Gerbing, Todd Alonzo, PhD, Paul M Sondel, MD, PhD

Blood (2008) 112 (11): 959.

https://doi.org/10.1182/blood.V112.11.959.959

Published: 2008

Journal Articles

Pediatric Patients with Extramedullary Leukemia Involving the Central Nervous System Have a Superior Outcome.

Donna Johnston, MD, FRCPC, Todd Alonzo, PhD, Robert Gerbing, Beverly Lange, MD, William G. Woods, MD

Blood (2008) 112 (11): 920.

https://doi.org/10.1182/blood.V112.11.920.920

Published: 2008

Journal Articles

High Level Expression of Wild Type FLT3 Is Associated with Poor Outcome and Selective Sensitivity to FLT3 Inhibitors in Childhood Acute Myeloid Leukemia: A Children’s Oncology Group Study

Patrick Brown, MD, Todd Alonzo, PhD, Robert Gerbing, Emily McIntyre, Beverly Lange, MD, Donald Small, Soheil Meshinchi, MD, PhD

Blood (2008) 112 (11): 147.

https://doi.org/10.1182/blood.V112.11.147.147

Published: 2008

Journal Articles

Prevalence and Prognostic Implications of WT1 Mutations in Pediatric AML Â: Report from Children’s Oncology Group

Jessica A Pollard, Rong Zeng, Phoenix Ho, Todd Alonzo, PhD, Robert Gerbing, Derek Stirewalt, Nyla A. Heerema, PhD, Susana C. Raimondi, PhD, Betsy Hirsch, Janet Franklin, MD, MPH, Beverly Lange, MD, Soheil Meshinchi, MD, PhD

Blood (2008) 112 (11): 143.

https://doi.org/10.1182/blood.V112.11.143.143

Published: 2008

Journal Articles

CEBPA Mutations Predict Favorable Prognosis in Pediatric AML

Phoenix Ho, Todd A. Alonzo, Robert B. Gerbing, Jessica A. Pollard, Derek Stirewalt, Craig Alan Hurwitz, Nyla A. Heerema, Betsy Hirsch, Susana C. Raimondi, Beverly Lange, Janet Franklin, Jerald Radich, Soheil Meshinchi

Blood (2008) 112 (11): 142.

https://doi.org/10.1182/blood.V112.11.142.142

Published: 2008

Journal Articles

A FISH 'n chips appetizer

Beverly Lange

Blood (2008) 111 (2): 480–481.

https://doi.org/10.1182/blood-2007-10-116053

Published: 2008

Journal Articles

Prevalence and Prognostic Implications of CEBPα Mutations in Pediatric AML.

Phoenix A. Ho, Todd A. Alonzo, Robert B. Gerbing, Jessica Pollard, Derek L. Stirewalt, Nyla A. Heerema, Beverly Lange, Jerald Radich, Soheil Meshinchi

Blood (2007) 110 (11): 1441.

https://doi.org/10.1182/blood.V110.11.1441.1441

Published: 2007

NARROW

Significant Improvements in Survival for Patients with t(6;9)(p23;q34)/ DEK-NUP214 in Contemporary Trials with Intensification of Therapy: A Report from the Children's Oncology Group

Acute Myeloid Leukemia with t(6;9)(p23;q34) Is Associated Poor Outcome in Childhood AML Regardless of FLT3/ITD Status, A Report From Children's Oncology Group.

The Ratio of Alternate BIRC5 (Survivin) Splice Variants Correlates with Refractory Disease and Poor Outcome in Children with Acute Myeloid Leukemia: A Report From the Children's Oncology Group,

FACS Analysis of Stat3/5 Signaling Reveals Ligand Sensitivity As a Significant Prognostic Factor in Pediatric AML: A Children's Oncology Group Report

TET2 Mutations Are Associated with Poor Outcome in Pediatric AML: A Report From the Children's Oncology Group

The Prevalence of Fanconi Anemia Among Patients with De Novo Acute Myelogenous Leukemia

TET2 SNP rs2454206 (I1762V) Correlates with Improved Survival In Pediatric Acute Myelogenous Leukemia, a Report From the Children's Oncology Group

The WT1 synonymous SNP rs16754 Is Associated with Higher mRNA Expression and Predicts Significantly Improved Outcome In Favorable-Risk Pediatric AML: a Report From the Children's Oncology Group

Germline Genetic Variation and Treatment Response on CCG-1891

Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

RUNX1 Mutations in Pediatric AML: A Report From the Children's Oncology Group.

Prevalence and Clinical Implications of N-RAS Mutations in Childhood AML – A Report From the Children's Oncology Group.

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Clinical and Serologic Interleukin 2 Receptor α Response to Interleukin-2 in CCG-2961, a Ranomized Phase 3 Trial for Pediatric Acute Myeloid Leukemia.

Pediatric Patients with Extramedullary Leukemia Involving the Central Nervous System Have a Superior Outcome.

High Level Expression of Wild Type FLT3 Is Associated with Poor Outcome and Selective Sensitivity to FLT3 Inhibitors in Childhood Acute Myeloid Leukemia: A Children’s Oncology Group Study

Prevalence and Prognostic Implications of WT1 Mutations in Pediatric AML Â: Report from Children’s Oncology Group

CEBPA Mutations Predict Favorable Prognosis in Pediatric AML

A FISH 'n chips appetizer

Prevalence and Prognostic Implications of CEBPα Mutations in Pediatric AML.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only